An eleven year follow-up of delayed-type hypersensitivity testing for the identification of HIV-1 infected patients at increased risk of developing AIDS

Scandinavian Journal of Infectious Diseases

Volumn 28, Issue 2, 1996, Pages 125-130

  Karlsson, Anders ^a   Moberg, Lars ^b   Bratt, Göran ^a   Halvarsson, Margit ^b   Von Krogh, Geo ^c   Morfeldt, Linda ^d   Sandström, Eric ^a  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b Huddinge Sjukhus   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d DANDERYD HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CELLULAR IMMUNITY; DELAYED HYPERSENSITIVITY; DISEASE PREDISPOSITION; FOLLOW UP; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RISK; SWEDEN;

EID: 0029941622     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549609049062     Document Type: Article

References (31)

1. Platt JL, Grant BW, Eddy AA, Michael AF. Immune cell populations in cutaneous delayed-typed hypersensitivity. J Exp Med 158: 1227-1242, 1983.
2. Kirkpatrick CH. Delayed hypersensitivity. In: Samter M, ed. Immunologic diseases, 4th edn. Boston: Little, Brown & Co., 270-273, 1988.
3. Waldmann TA. Immunodeficiency diseases: primary and acquired. In: Samter M, ed. Immunological disease, 4th edn. Boston: Little, Brown & Co., 411-465, 1988.
4. Polis MA, Masur H. Predicting the progression to AIDS. Am J Med 89: 701-705, 1990.
5. Schnittman SM, Psallidopoulos MC, Lane HC, Thompson L, Baseler M, Massari F, Fox CH, Salzman NP, Fauci AS. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 245: 305-308, 1989.
6. Michael NL, Vahey M, Burke DS, Redfield RR. Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease. J Virol 66: 310-316, 1992.
7. Fauci AS. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239: 617-622, 1988.
8. Teeuwsen VJP, Siebelink KHJ, de Wolf F, Goudsmit J, Uytde-Haag FGCM, Osterhaus ADME. Impairment of in vitro immune responses occurs within 3 months after HIV-1 seroconversion. AIDS 4: 77-81, 1990.
9. Bratt G, von Krogh G, Moberg L, Karlsson A, Putkonen PO, Biberfeld G, Böttiger M, Sandström E. Intradermal testing with multiple recall antigens for identification of cell-mediated immune deficiency in homosexual men. Clin Immunol Immunopathol 41: 206-215, 1986.
10. Birx DL, Brundage J, Larson K, Engler R, Smith L, Squire E, Carpenter G, Sullivan M, Rhoads J, Oster C, James W, Lupton G, Wierzba T, Burke D, Redfield R, Research TMM-CfAR. The prognostic utility of delayed-type hypersensitivity skin testing in the evaluation of HIV-infected patients. J Acquir Immune Defic Syndr 6: 1248-1257, 1993.
11. Karlsson A, Bratt G, von Krogh G, Morfeldt-Månson L, Böttiger B, Sandström E. A prospective study of 115 initially asymptomatic HIV infected gay men in Stockholm, Sweden. Scand J Infect Dis 23: 431-441, 1991.
12. Kniker WT, Anderson CT, McBryde JL, Roumiantzeff M, Lesourd B. Multitest CMI for standardized measurement of delayed cutaneous hypersensitivity and cell-mediated immunity. Normal values and proposed scoring system for healthy adults in the USA. Ann Allergy 52: 75-82, 1984.
13. CDC. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. MMWR 35: 334-339, 1986.
14. CDC. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 36(Suppl. 1): S1-S15, 1987.
15. von Krogh G, Broström C, Hermanson J, von Sydow M, Biberfeld G, Sandström E, Böttiger M. The introduction of HIV during 1979-80 in a sexually active homosexual population of Stockholm. Scand J Infect Dis 19: 285-288, 1987.
16. Cooper GS, Jeffers DJ. The clinical prognosis of HIV-1 infection: a review of 32 follow-up studies. J Gen Intern Med 3: 525-532, 1988.
17. Moss AR, Bacchetti P. Natural history of HIV infection. AIDS 3: 55-61, 1989.
18. Kaplan JE, Spira TJ, Fishbein DB, Lynn HS. Ten-year followup of HIV-infected homosexual men with lymphadenopathy syndrome: evidence for continuing risk of developing AIDS. J Acquir Immune Defic Syndr 5: 565-570, 1992.
19. Buchbinder SP, Katz M, Hessol N, O'Malley P, Barnhart J, Holmberg S. Healthy long-term positives: men infected with HIV for more than 10 years with CD4 counts greater than 500 cells. Int Conf AIDS (Netherlands) 8: abstr. TuC 0572, 1992.
20. Buchbinder S, Elbeik T, Harrer T, Feinberg MB, Walker BD, O'Malley PM, Scheer S, Holmberg S, Katz MH. Healthy long-term HIV positives: viral burden and cell-mediated immunity. Int Conf AIDS (Japan) 10: abstr. 007C, 1994.
21. Pedersen C, Gerstoft J, Tauris P, Lundgren JD, Gøtzsche PC, Buhl M, Salim Y, Schmidt K. Opportunistic infections and malignancies in 231 Danish AIDS patients. AIDS 4: 233-238, 1990.
22. Phair JP, Kauffman CA, Bjornson A. Investigation of host defense mechanisms in the aged as determinants of nosocomial colonization and pneumonia. J Reticulend Soc 23: 397, 1978.
23. Sohnle PG, Larson SE, Collins-Lech C, Guansing AR. Failure of lympholine-producing lymphocytes from aged humans to undergo activation by recall antigens. J Immunol 124: 2169, 1980.
24. Teasdale C, Hughes LE, Whithead RH, Newcombe RG. Factors affecting pretreatment immune competence in cancer patients. I. The effects of age, sex, and ill health. II. The corrected effects of malignant disease. Cancer Immunol Immunother 6: 88, 1979.
25. Roberts-Thomson IC, Whittingham S, Younchaiyud U, Mackay IR. Aging, immune response, and mortality. Lancet 7877: 368, 1974.
26. Waldorf DS, Willkens RF, Decker JL. Impaired delayed hypersensitivity in an aging population. JAMA 203: 831, 1968.
27. Grossman J, Baum J, Gluckman J, Fusner J, Condemi JJ. The effect of aging and acute illness on delayed hypersensitivity. J Allerg 55: 268, 1975.
28. Palmer DL, Reed WP. Delayed hypersensitivity skin testing. I. Response rates in a hospitalized population. J Infect Dis 130: 132, 1974.
29. Schnittman SM, Greenhouse JJ, Psallidopoulos MC, Baseler M, Salzman NP, Fauci AS, Lane HC. Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. Ann Intern Med 113: 438-443, 1990.
30. Saag MS, Crain MJ, Decker W, Campbell-Hill S, Robinson S, Brown WE, Leuther M, Whitley RJ, Hahn BH, Shaw GM. High-level viremia in adult and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels. J Infect Dis 164: 72-80, 1991.
31. Clerici M, Shearer GM. TH1 → TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 14: 107-111, 1993.